Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BNTX - Australia to offer fifth COVID shot to all adults later this month


BNTX - Australia to offer fifth COVID shot to all adults later this month

  • All Australian adults will be able to receive a fifth COVID-19 vaccine dose later this month, the country’s health minister, Mark Butler, announced Wednesday.
  • “From February 20, all adults who have not had a COVID-19 booster or a confirmed case in the past six months can now get another booster to give them additional protection against severe illness from COVID,” he said.
  • The announcement follows a recommendation from the Australian Technical Advisory Group on Immunisation (Atagi).
  • Atagi particularly endorsed the 2023 booster dose for those over 65 and younger adults with medical comorbidities, disability, or complex health needs, the minister said.
  • While all COVID shots are expected to provide benefits as a fifth dose, Omicron-adjusted messenger RNA shots are preferred for this purpose , the minister added.
  • Australia has so far authorized COVID-19 vaccines developed by Pfizer ( NYSE: PFE )/ BioNTech ( NASDAQ: BNTX ), Moderna ( NASDAQ: MRNA ), Novavax ( NVAX ), Johnson & Johnson ( JNJ ), and AstraZeneca ( AZN ).
  • Read: Seeking Alpha contributor Juxtaposed Ideas recently upgraded Pfizer ( PFE ) to Buy from Hold despite the waning demand for its jointly-developed COVID shot.

For further details see:

Australia to offer fifth COVID shot to all adults later this month
Stock Information

Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de

Menu

BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...